Published in Circulation on March 01, 1991
Triage of patients for short term observation after elective coronary angioplasty. Heart (2000) 1.97
Quantitative angiography after directional coronary atherectomy. Br Heart J (1991) 0.91
A pilot study of coronary angioplasty in outpatients. Br Heart J (1994) 0.87
Left main coronary artery dissection during percutaneous coronary intervention treated by stenting. Neth Heart J (2002) 0.83
A new stent graft. With thin walled controlled micropored polymer covering. Interv Neuroradiol (2001) 0.80
Ticlopidine and aspirin interactions. Heart (1997) 0.79
Inhibition of angiotensin converting enzyme cannot prevent increases in angiotensin II production in coronary circulation. Heart (2000) 0.77
Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial. Heart (2000) 0.77
Early and late effects of coumarin therapy started before percutaneous coronary intervention: Clinical, angiographic and cost-effective outcome of the Balloon Angioplasty and Anticoagulation Study (BAAS). Neth Heart J (2002) 0.75
High-density lipoprotein: a novel target for antirestenosis therapy. Clin Transl Sci (2014) 0.75
Coronary angioscopy. Tex Heart Inst J (1995) 0.75
Heparin in interventional radiology: a therapy in evolution. Semin Intervent Radiol (2005) 0.75
Prediction of success and major complications during elective coronary angioplasty. Neth Heart J (2001) 0.75
Intracoronary Multi-link stents: experience in 218 patients using aspirin alone. Heart (1998) 0.75
Coronary artery stents. Postgrad Med J (1996) 0.75
Temporary stent as a bail-out device during percutaneous transluminal coronary angioplasty: preliminary clinical experience. Br Heart J (1994) 0.75
A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med (1993) 4.49
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82
Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med (1999) 3.81
Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation (1998) 3.70
A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol (1997) 3.33
Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet (1985) 3.13
Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J (2002) 2.98
Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction. Heart (1997) 2.93
Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation (2001) 2.66
Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation (1985) 2.61
Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol (1986) 2.58
Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. Eur Heart J (2003) 2.49
Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart (2008) 2.40
Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation (2001) 2.28
Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation (2000) 2.28
A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med (1993) 2.18
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation (1997) 2.15
Late coronary occlusion after intracoronary brachytherapy. Circulation (1999) 2.09
Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation (2001) 1.91
Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation (2001) 1.89
Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J (2001) 1.85
Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med (2001) 1.84
Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol (1998) 1.77
Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris. Eur Heart J (1990) 1.74
Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation (1988) 1.74
Emergency coronary angioplasty in refractory unstable angina. N Engl J Med (1985) 1.73
Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J (2001) 1.71
Morphological and mechanical information of coronary arteries obtained with intravascular elastography; feasibility study in vivo. Eur Heart J (2002) 1.70
Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J (2004) 1.66
A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J (1999) 1.66
Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. GUSTO-1 Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol (1998) 1.65
Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty. Cathet Cardiovasc Diagn (1997) 1.64
A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J (1999) 1.61
ECG-gated versus nongated three-dimensional intracoronary ultrasound analysis: implications for volumetric measurements. Cathet Cardiovasc Diagn (1998) 1.60
Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. Eur Heart J (1995) 1.60
Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol (1986) 1.57
Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol (1997) 1.57
Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina. Circulation (2002) 1.56
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Is intravascular ultrasound after coronary stenting a safe procedure? Three cases of stent damage attributable to ICUS in a tantalum coil stent. Cathet Cardiovasc Diagn (1997) 1.55
Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J (1996) 1.54
Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis. Circulation (1995) 1.53
Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1,445 successfully dilated lesions. J Am Coll Cardiol (1992) 1.52
Value of coronary stenotic flow velocity acceleration in prediction of angiographic restenosis following balloon angioplasty. Eur Heart J (2002) 1.52
Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome. Eur Heart J (2002) 1.51
Prediction of restenosis after coronary balloon angioplasty. Results of PICTURE (Post-IntraCoronary Treatment Ultrasound Result Evaluation), a prospective multicenter intracoronary ultrasound imaging study. Circulation (1997) 1.51
Geometric vascular remodeling after balloon angioplasty and beta-radiation therapy: A three-dimensional intravascular ultrasound study. Circulation (1999) 1.50
Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation (2002) 1.49
Percutaneous transradial artery approach for coronary stent implantation. Cathet Cardiovasc Diagn (1993) 1.49
Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation (2000) 1.48
Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J (2004) 1.48
Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-up. Eur Heart J (2001) 1.47
Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. Circulation (1984) 1.46
Characterization of plaque components and vulnerability with intravascular ultrasound elastography. Phys Med Biol (2000) 1.46
Interventional cardiology in Europe 1994. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1998) 1.44
Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. European Angiopeptin Study Group. Circulation (1995) 1.44
Frontiers in interventional cardiology. Circulation (1998) 1.44
Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty. Heart (2000) 1.44
Limitation of myocardial infarct size after primary angioplasty: is a higher patency the only mechanism? Am Heart J (1999) 1.43
Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial. Eur Heart J (1999) 1.43
Principles of interpretation of coronary velocity and pressure tracings. Eur Heart J (1995) 1.43
Assessment of "silent" restenosis and long-term follow-up after successful angioplasty in single vessel coronary artery disease: the value of quantitative exercise electrocardiography and quantitative coronary angiography. J Am Coll Cardiol (1990) 1.41
Flow velocity and predictors of a suboptimal coronary flow velocity reserve after coronary balloon angioplasty. Eur Heart J (2002) 1.41
Benestent II, a remake of benestent I? Or a step towards the era of stentoplasty? Eur Heart J (1999) 1.41
Outpatient coronary stent implantation. J Am Coll Cardiol (1997) 1.40
The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantation. Eur Heart J (2001) 1.40
Comparison of brachytherapy strategies based on dose-volume histograms derived from quantitative intravascular ultrasound. Cardiovasc Radiat Med (2001) 1.40
Does the method of transluminal coronary revascularisation influence re-stenosis? Balloon angioplasty, atherectomy and stents compared. Br J Clin Pract (1995) 1.40
Initial observation regarding changes in vessel dimensions after balloon angioplasty and stenting followed by catheter-based beta-radiation. Is stenting necessary in the setting of catheter-based radiotherapy? Eur Heart J (2002) 1.40
25 years of aortic valve replacement using mechanical valves. Risk factors for early and late mortality. Eur Heart J (1997) 1.40
Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions. Int J Card Imaging (2000) 1.39
Women fare no worse than men 10 years after attempted coronary angioplasty. Cathet Cardiovasc Diagn (1996) 1.39
Videodensitometric quantitative angiography after coronary balloon angioplasty, compared to edge-detection quantitative angiography and intracoronary ultrasound imaging. Eur Heart J (2000) 1.39
[Complications shortly after transluminal angioplasty or following coronary surgery in 183 comparable patients with multi-vessel coronary disease]. Ned Tijdschr Geneeskd (1994) 1.39
Vineberg revisited. Long-term survival more than two decades after direct surgical myocardial revascularization. Int J Cardiol (2000) 1.39
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation (1996) 1.39
Routine intracoronary beta-irradiation. Acute and one year outcome in patients at high risk for recurrence of stenosis. Eur Heart J (2002) 1.38
In vitro study of FFR, QCA, and IVUS for the assessment of optimal stent deployment. Catheter Cardiovasc Interv (2001) 1.38
Clinical and angiographical follow-up after implantation of a 6--12 microCi radioactive stent in patients with coronary artery disease. Eur Heart J (2001) 1.38
[Percutaneous transluminal coronary angioplasty in 1980-85 and 1995-96: more frequent multivessel disease, fewer reoperations and no change in mortality 1 and 5 years postoperatively]. Ned Tijdschr Geneeskd (2002) 1.38
Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.36
The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovasc Med (2005) 1.35
Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart (2009) 1.35
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32
Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation (1994) 1.32
Coronary artery dimensions from cineangiograms methodology and validation of a computer-assisted analysis procedure. IEEE Trans Med Imaging (1984) 1.31
Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol (1994) 1.30